[1]
C. Hong, S. Kim, G. Curnew, S. Schulman, E. Pullenayegum, and A. Holbrook, “VALIDATION OF A PATIENT DECISION AID FOR CHOOSING BETWEEN DABIGATRAN AND WARFARIN FOR ATRIAL FIBRILLATION”, J Popl Ther Clin Pharmacol, vol. 20, no. 3, Sep. 2013, Accessed: Nov. 19, 2024. [Online]. Available: https://mail.jptcp.com/index.php/jptcp/article/view/357